Scarica l'app Stockscreener
44.67
1.99%
0.87
Dopo l'orario di chiusura:
44.67
Anaptysbio Inc Borsa (ANAB) Ultime notizie
AnaptysBio (NASDAQ:ANAB) Shares Gap Down Following Insider Selling - MarketBeat
Is AnaptysBio Inc. stock positioned for digital transformationGrip and Outsole Review & HOKA model picks for your routine - ulpravda.ru
AnaptysBio (NASDAQ:ANAB) Upgraded at UBS Group - MarketBeat
AnaptysBio Moves to Toss GSK/Tesaro Repudiation Claim Over Jemperli Royalties - prismedia.ai
Anaptysbio CFO Mulroy sells $86k in shares By Investing.com - Investing.com Canada
What dividend safety score for AnaptysBio Inc. stockPortfolio Return Report & AI Optimized Trading Strategy Guides - ulpravda.ru
Anaptysbio CFO Mulroy sells $86k in shares - Investing.com
Anaptysbio chief legal officer Loumeau sells $439k in stock - Investing.com
AnaptysBio CMO Lizzul sells $100k in stock - Investing.com
AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty - Reuters
Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary - The Manila Times
AnaptysBio files motion to dismiss in Tesaro/GSK royalty dispute - Investing.com
AnaptysBio, Inc. Files Motion to Dismiss Breach of Contract Claim Amid Ongoing Dispute with Tesaro and GSK, Trial Set for July 2026 - Quiver Quantitative
Anaptys Files Motion to Dismiss Tesaro’s Claim of - GlobeNewswire
AnaptysBio (NASDAQ:ANAB) Insider Eric Loumeau Sells 9,639 Shares - MarketBeat
Insider Selling: AnaptysBio (NASDAQ:ANAB) CEO Sells $415,102.22 in Stock - MarketBeat
AnaptysBio (NASDAQ:ANAB) Insider Sells $100,820.85 in Stock - MarketBeat
Why analysts upgrade AnaptysBio Inc. stockEarnings Growth Summary & Weekly High Conviction Trade Ideas - ulpravda.ru
Will AnaptysBio Inc. stock reach Wall Street targets2025 Market Sentiment & Accurate Intraday Trade Tips - ulpravda.ru
Can AnaptysBio Inc. stock sustain market leadershipRecession Risk & Daily Technical Forecast Reports - ulpravda.ru
Is AnaptysBio Inc. stock a buy in volatile marketsResistance Breakout Alerts & Build Balanced Portfolio - ulpravda.ru
UBS Raises AnaptysBio (ANAB) Price Target to $70, Upgrades to Buy | ANAB Stock News - GuruFocus
AnaptysBio (NASDAQ:ANAB) Shares Gap UpHere's Why - MarketBeat
AnaptysBio stock rating initiated at Buy by UBS with $70 price target - Investing.com Canada
Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference - Sahm
AnaptysBio (NASDAQ:ANAB) Insider Paul Lizzul Sells 4,219 Shares - MarketBeat
Anaptysbio CLO Eric Loumeau sells $129k in shares By Investing.com - Investing.com Canada
Anaptysbio CFO Mulroy sells $145k in shares By Investing.com - Investing.com Canada
Anaptysbio CEO Faga sells $662k in shares - Investing.com
Insider Selling: AnaptysBio (NASDAQ:ANAB) Insider Sells 2,983 Shares of Stock - MarketBeat
Anaptysbio CLO Eric Loumeau sells $129k in shares - Investing.com
AnaptysBio, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 - Quiver Quantitative
AnaptysBio, Inc. $ANAB Shares Sold by Voya Investment Management LLC - MarketBeat
Is AnaptysBio Inc AN6 a good long term investmentTrading Volume Surges & High Profit Investment Ideas - earlytimes.in
New Highs: Is AnaptysBio Inc stock a safe haven assetEarnings Growth Report & AI Forecasted Stock Moves - moha.gov.vn
Anaptysbio CEO Faga sells $662k in shares By Investing.com - Investing.com Canada
This biotech stock has more than tripled in 2025, but red flags are waving - MSN
AnaptysBio (NASDAQ:ANAB) Stock Price Down 4%Should You Sell? - MarketBeat
Trade Alert: Independent Director Of AnaptysBio J. Ware Has Sold Stock - simplywall.st
AnaptysBio (NASDAQ:ANAB) Hits New 12-Month HighTime to Buy? - MarketBeat
AnaptysBio stock hits 52-week high at $51.58 - Investing.com
AnaptysBio stock hits 52-week high at $51.58 By Investing.com - Investing.com South Africa
Insider Selling: AnaptysBio (NASDAQ:ANAB) Director Sells 3,900 Shares of Stock - MarketBeat
AnaptysBio (NASDAQ:ANAB) Insider Sells $75,000.00 in Stock - MarketBeat
AnaptysBio (NASDAQ:ANAB) CFO Dennis Mulroy Sells 10,000 Shares - MarketBeat
AnaptysBio (NASDAQ:ANAB) Insider Eric Loumeau Sells 10,000 Shares - MarketBeat
Anaptysbio Insider Sold Shares Worth $510,000, According to a Recent SEC Filing - marketscreener.com
Anaptysbio Insider Sold Shares Worth $500,000, According to a Recent SEC Filing - marketscreener.com
AnaptysBio Executives and Director Execute Stock Sales - TradingView — Track All Markets
AnaptysBio Executives Sell Shares - TradingView — Track All Markets
AnaptysBio (NASDAQ: ANAB) CMO reports option exercise and stock sale - Stock Titan
AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
AnaptysBio sets $100M stock repurchase plan - MSN
How AnaptysBio Inc. (AN6) stock trades under stagflationJuly 2025 Spike Watch & Smart Allocation Stock Reports - Улправда
This Biotech Stock Has More Than Tripled in 2025, but Red Flags Are Waving - Yahoo Finance
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):